On Tuesday, Shockwave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 67 to 75.
When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.
This unique rating identifies technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the trailing 52 weeks stacks up against all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 in the early stages of their moves. See if Shockwave Medical stock can continue to rebound and hit that benchmark.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Shockwave Medical Stock A Buy?
Shockwave Medical gapped up Tuesday, retaking its 200-moving average. While it's not currently an ideal time to buy shares, see if the stock will be able to form a base and break out.
The medical device maker company showed 232% EPS growth in the latest quarterly report. Sales rose 71%. Keep an eye out for the company's next round of numbers on or around May 8.
Shockwave Medical stock earns the No. 5 rank among its peers in the Medical-Systems/Equipment industry group. Masimo and Bruker Corp are also among the group's highest-rated stocks.
